A Proof-of-Principle Study of the Design and Optimization of a Novel Fluid-Driven Automated Retracting Needle System

2021 ◽  
Vol 15 (3) ◽  
Author(s):  
W. J. Geelhoed ◽  
M. Boonekamp ◽  
H. van de Stadt ◽  
S. Badulescu ◽  
R. A. Lalai ◽  
...  

Abstract The cannulation of blood vessels is one of the most basic and essential interventions in medical practice. A common adverse event of this procedure is miscannulation with infiltration of the second part of the vessel wall, often resulting in a perivascular hematoma. In hemodialysis patients, surgically created arteriovenous conduits are cannulated 3–4 times per week to provide sufficient blood supply to the hemodialysis machine. However, the high blood flow and pressure in these vascular access sites increase the risk of complications upon miscannulation. A novel needle system that allows for rapid automatic retraction of the needle in response to contact with blood after positioning the cannula in the blood vessel was developed to reduce the risk of miscannulation. The device can easily be incorporated into existing needle designs. The mechanical functionality of the device was validated by testing prototypes in an ex vivo system. Optimization of the needle system was performed to enhance response time and piston shape. A final prototype design was manufactured and validated. The optimal membrane composition and piston shape were determined, which resulted in a needle response time of 40 ms upon contact with fluid at a pressure of 100 mmHg (arterial pressure). Here, we have successfully designed, mechanically validated, and tested a novel automated rapid needle retraction system that allows incorporation into existing needle systems. This device could notably decrease the difficulty of vessel cannulation and the prevalence of hematoma formation.

Pharmaceutics ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 544
Author(s):  
Miao Wang ◽  
Sung-Kyun You ◽  
Hong-Ki Lee ◽  
Min-Gu Han ◽  
Hyeon-Min Lee ◽  
...  

Docetaxel (DTX) has clinical efficacy in the treatment of breast cancer, but it is difficult to develop a product for oral administration, due to low solubility and permeability. This study focused on preparing a self-microemulsifying drug delivery system (SME) loaded with DTX-phospholipid complex (DTX@PLC), to improve the dissolution and gastrointestinal (GI) permeability of DTX. A dual technique combining the phospholipid complexation and SME formulation described as improving upon the disadvantages of DTX has been proposed. We hypothesized that the complexation of DTX with phospholipids can improve the lipophilicity of DTX, thereby increasing the affinity of the drug to the cell lipid membrane, and simultaneously improving permeability through the GI barrier. Meanwhile, DTX@PLC-loaded SME (DTX@PLC-SME) increases the dissolution and surface area of DTX by forming a microemulsion in the intestinal fluid, providing sufficient opportunity for the drug to contact the GI membrane. First, we prepared DTX@PLC-SME by combining dual technologies, which are advantages for oral absorption. Next, we optimized DTX@PLC-SME with nanosized droplets (117.1 nm), low precipitation (8.9%), and high solubility (33.0 mg/g), which formed a homogeneous microemulsion in the aqueous phase. Dissolution and cellular uptake studies demonstrated that DTX@PLC-SME showed 5.6-fold higher dissolution and 2.3-fold higher DTX uptake in Caco-2 cells than raw material. In addition, an ex vivo gut sac study confirmed that DTX@PLC-SME improved GI permeability of DTX by 2.6-fold compared to raw material. These results suggested that DTX@PLC-SME can significantly overcome the disadvantages of anticancer agents, such as low solubility and permeability.


Thorax ◽  
2018 ◽  
Vol 73 (10) ◽  
pp. 918-925 ◽  
Author(s):  
Emma M Pinder ◽  
Anthony J Rostron ◽  
Thomas P Hellyer ◽  
Marie-Helene Ruchaud-Sparagano ◽  
Jonathan Scott ◽  
...  

BackgroundCritically ill patients with impaired neutrophil phagocytosis have significantly increased risk of nosocomial infection. Granulocyte-macrophage colony-stimulating factor (GM-CSF) improves phagocytosis by neutrophils ex vivo. This study tested the hypothesis that GM-CSF improves neutrophil phagocytosis in critically ill patients in whom phagocytosis is known to be impaired.MethodsThis was a multicentre, phase IIa randomised, placebo-controlled clinical trial. Using a personalised medicine approach, only critically ill patients with impaired neutrophil phagocytosis were included. Patients were randomised 1:1 to subcutaneous GM-CSF (3 μg/kg/day) or placebo, once daily for 4 days. The primary outcome measure was neutrophil phagocytosis 2 days after initiation of GM-CSF. Secondary outcomes included neutrophil phagocytosis over time, neutrophil functions other than phagocytosis, monocyte HLA-DR expression and safety.ResultsThirty-eight patients were recruited from five intensive care units (17 randomised to GM-CSF). Mean neutrophil phagocytosis at day 2 was 57.2% (SD 13.2%) in the GM-CSF group and 49.8% (13.4%) in the placebo group, p=0.73. The proportion of patients with neutrophil phagocytosis≥50% at day 2, and monocyte HLA-DR, appeared significantly higher in the GM-CSF group. Neutrophil functions other than phagocytosis did not appear significantly different between the groups. The most common adverse event associated with GM-CSF was fever.ConclusionsGM-CSF did not improve mean neutrophil phagocytosis at day 2, but was safe and appeared to increase the proportion of patients with adequate phagocytosis. The study suggests proof of principle for a pharmacological effect on neutrophil function in a subset of critically ill patients.


Nanomaterials ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2920
Author(s):  
Ameeduzzafar Zafar ◽  
Syed Sarim Imam ◽  
Nabil K. Alruwaili ◽  
Omar Awad Alsaidan ◽  
Mohammed H. Elkomy ◽  
...  

Hypertension is a cardiovascular disease that needs long-term medication. Oral delivery is the most common route for the administration of drugs. The present research is to develop piperine self-nanoemulsifying drug delivery system (PE-SNEDDS) using glyceryl monolinoleate (GML), poloxamer 188, and transcutol HP as oil, surfactant, and co-surfactant, respectively. The formulation was optimized by three-factor, three-level Box-Behnken design. PE-SNEDDs were characterized for globule size, emulsification time, stability, in-vitro release, and ex-vivo intestinal permeation study. The optimized PE-SNEDDS (OF3) showed the globule size of 70.34 ± 3.27 nm, percentage transmittance of 99.02 ± 2.02%, and emulsification time of 53 ± 2 s Finally, the formulation OF3 was transformed into solid PE-SNEDDS (S-PE-SNEDDS) using avicel PH-101 as adsorbent. The reconstituted SOF3 showed a globule size of 73.56 ± 3.54 nm, PDI of 0.35 ± 0.03, and zeta potential of −28.12 ± 2.54 mV. SEM image exhibited the PE-SNEDDS completely adsorbed on avicel. Thermal analysis showed the drug was solubilized in oil, surfactant, and co-surfactant. S-PE-SNEDDS formulation showed a more significant (p < 0.05) release (97.87 ± 4.89% in 1 h) than pure PE (27.87 ± 2.65% in 1 h). It also exhibited better antimicrobial activity against S. aureus and P. aeruginosa and antioxidant activity as compared to PE dispersion. The in vivo activity in rats exhibited better (p < 0.05) antihypertensive activity as well as 4.92-fold higher relative bioavailability than pure PE dispersion. Finally, from the results it can be concluded that S-PE-SNEDDS might be a better approach for the oral delivery to improve the absorption and therapeutic activity.


Author(s):  
Johan Malmqvist

Abstract This paper describes a system for parametric design and optimization of complex products. In the system, the use of knowledge-based and mathematical programming methods is combined. The motivation is that while knowledge-based methods are well suited for modeling products, they are insufficient when dealing with design problems that can be given an optimization formulation. This weakness was approached by including the information necessary for stating an optimization problem in the product models. A system optimization method can then be applied. The system also performs sensitivity analysis and has an interactive optimization module. The use of the system is illustrated by an example; the design and optimization of a two-speed gearbox.


Author(s):  
Paolo Caravaggi ◽  
Elisa Assirelli ◽  
Andrea Ensini ◽  
Maurizio Ortolani ◽  
Erminia Mariani ◽  
...  

Osteoarthritis (OA) is an evolving disease and a major cause of pain and impaired mobility. A deeper understanding of cartilage metabolism in response to loading is critical to achieve greater insight into OA mechanisms. While physiological joint loading helps maintain cartilage integrity, reduced or excessive loading have catabolic effects. The main scope of this study is to present an original methodology potentially capable to elucidate the effect of cyclic joint loading on cartilage metabolism, to identify mechanisms involved in preventing or slowing down OA progression, and to provide preliminary data on its application. In the proposed protocol, the combination of biomechanical data and medical imaging are integrated with molecular information about chondrocyte mechanotransduction and tissue homeostasis. The protocol appears to be flexible and suitable to analyze human OA knee cartilage explants, with different degrees of degeneration, undergoing ex vivo realistic cyclic joint loading estimated via gait analysis in patients simulating mild activities of daily living. The modulation of molecules involved in cartilage homeostasis, mechanotransduction, inflammation, pain and wound healing can be analyzed in chondrocytes and culture supernatants. A thorough analysis performed with the proposed methodology, combining in vivo functional biomechanical evaluations with ex vivo molecular assessments is expected to provide new insights on the beneficial effects of physiological loading and contribute to the design and optimization of non-pharmacological treatments limiting OA progression.


2001 ◽  
Author(s):  
Aaron R. Byerley ◽  
Harry N. Newton ◽  
John R. Tuite

Abstract This paper describes a thermal system analysis, design, and optimization project that has been successfully used for two years in an introductory engineering thermodynamics course. The project has provided the students with an opportunity to gain a first-order understanding of the optimization process through the use of spreadsheets and math applications packages. The assignment has been based on the modeling and optimization of a non-ideal gas turbine cycle for use in an Unlimited Class Hydroplane. Student teams are guided through the five steps of the engineering design process including 1.) “information gathering” using mostly web-based material; 2.) “problem definition and alternative generation” using the rules published by the Unlimited Class Hydroplane Racing Association; 3.) “evaluation” of the alternatives using a predictive model based upon thermodynamic principles; 4.) “decision making” using graphical and numerical results generated by spreadsheets and math applications packages; and 5.) “presentation” of the design recommendations in both oral and written reports. Compressor pressure ratio and isentropic efficiencies for the compressor and turbine were the three design variables. Penalty functions were assigned to each to account for component cost, weight, volume, and complexity. The objective function was defined as the ratio of “shaft power to total penalty units” and was maximized using surface plots generated in Excel 97. The optimal solution was also obtained using Mathcad 8.0, Mathematica 3.0, Solver (an add-in tool for Excel 97), and Ada 95, a general programming language. Animated surface plots clearly illustrated the underlying mathematical operations of optimizing a system of non-linear equations.


Author(s):  
Jianming Cao ◽  
Paul Allaire ◽  
Timothy Dimond ◽  
Saeid Dousti

This paper forms Part II of the rotor drop analysis, focusing on the auxiliary bearing system design and optimization based on the rotor drop analysis methods, as introduced in Part I. Optimization focuses on shaft orbit, maximum ball bearing stress, and how to avoid possible ball bearing damage due to impact loading during rotor drop by optimizing auxiliary design including bearing selection, preload method, radial and axial damping element, and flexible bearing support. Using the detailed rotor drop model and time transient method, a variety of simulations are presented for 1) an energy storage vertical flywheel system, and 2) an 8-stage horizontal centrifugal compressor, are conducted to investigate the effects of auxiliary bearing design and to optimize the auxiliary system. Axial drops, radial drops and combination of radial/axial drops are all evaluated considering angular contact auxiliary bearing size, number of rows, preload, and flexible damped bearing supports in the axial and radial directions. The rotor drop analysis method introduced in this paper may be used as a design toolbox for the auxiliary bearing system.


2012 ◽  
Vol 2012 ◽  
pp. 1-10 ◽  
Author(s):  
Shengyong Chen ◽  
Yujun Zheng ◽  
Carlo Cattani ◽  
Wanliang Wang

This article summarizes some methods from biological intelligence for modeling and optimization of supply chain management (SCM) systems, including genetic algorithms, evolutionary programming, differential evolution, swarm intelligence, artificial immune, and other biological intelligence related methods. An SCM system is adaptive, dynamic, open self-organizing, which is maintained by flows of information, materials, goods, funds, and energy. Traditional methods for modeling and optimizing complex SCM systems require huge amounts of computing resources, and biological intelligence-based solutions can often provide valuable alternatives for efficiently solving problems. The paper summarizes the recent related methods for the design and optimization of SCM systems, which covers the most widely used genetic algorithms and other evolutionary algorithms.


Author(s):  
George M. Bacioiu ◽  
Zbigniew J. Pasek

Product/process design and optimization are typically aimed at a single product for a single customer. Such approach, however, often leads to underutilization of available production capacity. It is therefore reasonable for the manufacturer to make an effort to minimize available excess capacity to improve overall facility performance. Excess capacity can be allocated to the production of another product/process design, which can be also independently optimized. However, exploring possible synergies between the two products/processes may bring higher benefits. This paper presents a case where a manufacturing process (plastic blow moulding) was shared among two different products for two different customers, each with a different set of needs. These customer needs were mapped into core value-creating processes, recognizing both the differences in their requirements as well as the similarities in their expectations. Conflicting differences in complexity, production volumes and quality requirements were reconciled using QFD_based approach, and led to improved customer satisfaction and cost performance.


Blood ◽  
2010 ◽  
Vol 116 (21) ◽  
pp. 2595-2595
Author(s):  
Adam W. Mailloux ◽  
Fanqi Bai ◽  
Ling Zhang ◽  
Eric Padron ◽  
Lili Yang ◽  
...  

Abstract Abstract 2595 Large Granular Lymphocyte (LGL) leukemia is a chronic lymphoproliferative syndrome that can be broadly classified into two groups depending on whether the expanded cells are T-cells or NK-cells. The clinical characteristics of the disease include lymphocytosis, neutropenia, anemia, that can be associated with rheumatoid arthritis and pulmonary arterial hypertension (PAH). Hematologic improvement with immunosuppressive agents such as cyclosporine and low-dose methotrexate has lead to the widely accepted theory that cytopenias are mediated by autoimmune destruction of the hematopoietic stem cell (HSC) compartment or lysis of mature myeloid cells in circulation. We found, however, that autologous HSCs and mature granulocyte populations fail to be recognized or lysed ex vivo by T-LGL leukemia cells suggesting that an alternate mechanism may be involved. In contrast to research done on the T-LGL cells themselves, the role of the bone marrow microenvironment and HSC compartment in T-LGL leukemia patients is completely unexplored. Therefore, bone marrow core biopsies, aspirates, and peripheral blood smears were obtained from 22 patients with LGL leukemia and 14 patients with non-hematological malignancies to serve as controls. Morphology and extracellular matrix composition were examined by H&E and reticulin stains, respectively. Utilizing the European consensus guidelines, grading scale (0 – 3), we determined that bone marrow reticulin fibrosis is present in patients with T-LGL leukemia (Figure 1). The mean fibrosis grade for the LGL group was 2.32 (median of 2.5), whereas, the mean fibrosis grade for the control group was 1.46 (median of 1.50), p-value of 0.01. Our analysis revealed that reticulin fibrosis in LGL leukemia bone marrow was particularly associated with the interstitial stroma and lymphoid aggregates. The degree of fibrosis in T-LGL bone marrow showed no relation to absolute neutrophil counts. However, an in depth analysis of neutrophil morphology revealed several dysplastic features within the neutrophil compartment in T-LGL patients. These features include decreased segmentation, increased numbers of pseudo-Pelger-Huet forms, and an increase percentage of immature neutrophils. Of these, the proportion of immature neutrophils positively correlated with fibrosis grade in T-LGL patients (Spearman r=0.7302; p=0.0002), indicating a possible link between reticulin fibrosis and the quality of hematopoiesis. To explore the pathogenesis of medullary fibrosis, mesenchymal stem cells (MSCs) were isolated from bone marrow aspirates of 6 LGL leukemia patients and 5 healthy controls and then expanded ex vivo under non-differentiating conditions. During expansion, healthy MSCs produce cytokines and growth factors necessary for self renewal and for the support of hematopoiesis. However, MSCs from T-LGL patients displayed severely reduced self-renewal potential, reaching a mean of 7 population doublings compared to a mean of 23 for normal MSCs, and were unable to support the proliferation of healthy HSCs in a co-culture proliferation assay. Microarray analysis (H6 V133 plus 2.0) was performed on the MSCs from both control and T-LGL patients with analysis focused on genes regulating basement membrane composition. For normal MSCs, significant reductions in the expression of numerous collagen genes occured as the cells underwent expansion in self-renewal conditions. However, MSCs from T-LGL patients failed to downregulate these genes despite months of culture. The most prominent collagen genes following this pattern were types I (α1, α2), III (reticulin), IV (α1, α2), and V (α1, α2). A combination of qRT-PCR and immunflourescent staining (Figure 2) were utilized to confirm these gene expression changes. Collectively, these results implicate aberrant MSC self-renewal capacity and skewed basement membrane protein expression in the pathogenesis of T-LGL leukemia and suggest that these abnormalities may represent novel targets for future drug discovery. Figure 1: T-LGL patients have increase reticulin fibrosis in bone marrow stroma. Paraffin embeddeb from control (a) or T-LGL patient (b) bone marrow biopsies with reticulin. Figure 1:. T-LGL patients have increase reticulin fibrosis in bone marrow stroma. Paraffin embeddeb from control (a) or T-LGL patient (b) bone marrow biopsies with reticulin. Figure 2: MSCs from T-LGL patients display altered basement membrane composition following ex vivo expansion. Immunofluorescent staining for collagen type I (green), collagen type II (red), and DAPI (blue) was performed on primary MSCs isolated from the bone marrow of normal donors at early passage (a), late passage (b), or T-LGL patients at late passage. Figure 2:. MSCs from T-LGL patients display altered basement membrane composition following ex vivo expansion. Immunofluorescent staining for collagen type I (green), collagen type II (red), and DAPI (blue) was performed on primary MSCs isolated from the bone marrow of normal donors at early passage (a), late passage (b), or T-LGL patients at late passage. Disclosures: No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document